NCT07536100Recruiting
VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia
Effectiveness and Tolerability of VENEZE Peptide Factor Hair Serum for Pattern Hair Loss: A Randomized Double-blind Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Institute of Dermatology, Thailand
- Participants (registry)
- 80
- Start
- May 2026
- Primary completion
- November 2026 (planned)
- Study completion
- November 2026 (planned)
- Last registry update
- May 2026
- Countries
- Thailand
Conditions studied: Androgenetic Alopecia (AGA)
Interventions: Veneze peptide hair serum, Hair growth peptide serum, Topical minoxidil, Topical Minoxidil 2% solution
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.